DUBLIN, Ireland--(BUSINESS WIRE)--ICON (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of DOCS International, a leading European based clinical research staffing organisation, for a cash consideration of approximately $40 million.
